MyoPro Approved for Reimbursement by German Statutory Health Insurance
Approval To Be Determined on Case-by-Case Basis CAMBRIDGE, Mass., February 3, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Statutory Health Insurance in Germany has approved MyoPro for patients on […]
Myomo Announces One-for-Thirty Reverse Stock Split of its Common Stock
CAMBRIDGE, M.A. January 30, 2020 — Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, […]
Myomo Announces Partnership with Hobbs Rehabilitation for UK To Provide Specialist Neurological Rehabilitation Services
CAMBRIDGE, Mass., December 16, 2019 – Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has formed a partnership with Hobbs Rehabilitation to provide a range of services to support MyoPro® users […]
Myomo Reports Third Quarter 2019 Results
CAMBRIDGE, Mass., November 12, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the third quarter ended September 30, 2019. Read more.
Myomo to Report Third Quarter 2019 Results on November 12, 2019
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the third quarter ended September 30, 2019 on Tuesday, November 12, 2019, after the market […]
Myomo Closes $3M Term Loan
Proceeds from Non-Dilutive Financing to be Used to Achieve Near-Term Milestones CAMBRIDGE, Mass., October 23, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the“Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has entered into a term loan agreement […]
Myomo Announces Departure of Steve Sanghi from Board of Directors
Microchip Technology CEO will continue as advisor to Myomo and as an investor CAMBRIDGE, Mass., October 11, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the resignation of Steve Sanghi from […]
Myomo Announces Technology Licensing Program for International Markets
CAMBRIDGE, Mass., August 21, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has launched a business development program to bring its proprietary MyoPro orthotic product line to a greater […]
Myomo Reports Second Quarter 2019 Results
CAMBRIDGE, Mass., August 8, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the second quarter ended June 30, 2019. Read more.
Myomo to Report Second Quarter 2019 Results on August 8, 2019
Management to hold a conference call at 4:30 p.m. EDT CAMBRIDGE, Mass., August 1, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the […]